Laser-assisted deep sclerectomy better than conventional type

Article

Erbium YAG-laser-assisted deep sclerectomy (DS) offers greatly simplified dissection and better long-term intraocular pressure (IOP) control compared with conventional DS.

Erbium YAG-laser-assisted deep sclerectomy (DS) offers greatly simplified dissection and better long-term intraocular pressure (IOP) control compared with conventional DS, concludes a study published in the March issue of Eye.

Thomas Klink and co-workers from Julius-Maximilians-University and St Vincentius Hospital, Germany examined the data of 14 consecutive patients (10 male, four female) who underwent surgery between 1999 and 2000. The procedure was begun as a standard DS. The deep corneoscleral lamella was dissected with a pulsed Erbium YAG laser (energy: 40-100 mJ, frequency: 5-10 Hz). Schlemm's canal was unroofed and the lamella thinned until aqueous percolated continuously through the membrane.

Mean preoperative IOP was 37.7±10.5 mmHg. The mean postoperative IOP was 16.1±3.9 mmHg at one month, 15.1±4.3 mmHg at three months, 16.4±4.5 mmHg at 12 months and 17.6±8.7 mmHg at 50.5 months. The complete success rates (IOP ≤21 mmHg + IOP reduction ≥ 20% without glaucoma medication) were 83.3% at three months and 50% at 12 and 50.5 months. Rates for qualified success (IOP ≤21 mmHg + IOP reduction ≥ 20% with glaucoma medication) were 91.7% at three months, 92.9% at 12 months and 78.6% 50.5 months. The number of glaucoma medications was reduced from 3.07±0.92 preoperatively to 1.14±1.1 at 50.5 months. The only intraoperative complication requiring iridectomy was a single case of anterior chamber penetration.

It was the conclusion of the authors that Erbium YAG-laser-assisted DS offers better long-term IOP control than standard DS.

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Vikas Chopra at AAO 2024: Advancements in MIGS are transforming patient care
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Dr Rick Lewis discusses the FLigHT procedure and ViaLase laser at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) meeting
Osamah Saeedi, MD, MS, at ARVO 2024
Dr Nir Shoham Hazon, Director, Miramichi EyeNB Centre of Excellence, New Brunswick, Canada
© 2025 MJH Life Sciences

All rights reserved.